Prestige Consumer Healthcare Inc. (NYSE:PBH) Stake Cut by TD Asset Management Inc

Key Points

• TD Asset Management Inc has reduced its stock position in Prestige Consumer Healthcare Inc. by 11.4%, owning 28,000 shares valued at approximately $2.41 million.
• Several institutional investors have increased their stakes in Prestige Consumer Healthcare, with CIBC Private Wealth Group raising its position by nearly 49% in the last quarter.
• Prestige Consumer Healthcare reported a quarterly earnings per share of $1.32, exceeding expectations and showing a 7% revenue increase year-over-year, with projected earnings for the current fiscal year at 4.5 EPS.

TD Asset Management Inc decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 11.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,000 shares of the company's stock after selling 3,600 shares during the period. TD Asset Management Inc owned 0.06% of Prestige Consumer Healthcare worth $2,407,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its holdings in Prestige Consumer Healthcare by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock worth $105,342,000 after buying an additional 21,951 shares during the period. Kayne Anderson Rudnick Investment Management LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter valued at $84,932,000. Invesco Ltd. boosted its holdings in Prestige Consumer Healthcare by 2.4% in the 4th quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after purchasing an additional 24,392 shares during the period. Congress Asset Management Co. boosted its holdings in Prestige Consumer Healthcare by 9.1% in the 1st quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after purchasing an additional 82,838 shares during the period. Finally, Northern Trust Corp boosted its holdings in Prestige Consumer Healthcare by 10.9% in the 4th quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after purchasing an additional 80,055 shares during the period. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock traded down $0.22 during midday trading on Friday, hitting $73.73. The company had a trading volume of 423,917 shares, compared to its average volume of 427,792. The company's 50 day simple moving average is $80.65 and its 200 day simple moving average is $82.30. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The stock has a market cap of $3.64 billion, a price-to-earnings ratio of 17.19, a PEG ratio of 2.21 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. During the same quarter in the prior year, the firm earned $1.02 earnings per share. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on PBH shares. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.